Recent Articles from Investor Brand Network

C3is (NASDAQ: CISS), a ship-owning company providing dry bulk and tanker seaborne transportation services, announced the closing of its registered direct offering with institutional investors for the purchase and sale of 800,000 shares of common stock at $2.50 per share, resulting in gross proceeds of approximately $2 million. The transaction closed Oct. 9, 2025. C3is plans to use the net proceeds, together with existing cash, for general corporate purposes and working capital. Aegis Capital Corp. acted as exclusive placement agent for the offering, with Goodwin Procter LLP serving as U.S. counsel to the company and Kaufman & Canoles, P.C. serving as U.S. counsel to Aegis.

SKYX Platforms (NASDAQ: SKYX), a platform technology company with more than 100 pending and issued patents and over 60 lighting and home décor websites, issued a corporate update highlighting continued financial and operational progress. The company reported $15.7 million in cash as of June 30, 2025, followed by a $3.25 million raise from an existing lead investor in September. SKYX showcased its plug-and-play smart technologies during a Marriott Hotel renovation and secured major deployments, including more than 10,000 units for a 278-apartment project in Austin, Texas, and over 500,000 units for Miami’s $3 billion Urban Smart Home City. The company also announced a U.S. manufacturing partnership with Profab Electronics to strengthen its domestic supply chain, supplementing global production in Vietnam, Taiwan, China, and Cambodia. SKYX’s six consecutive quarters of revenue growth and 54% reduction in operating cash use reflect significant progress toward its goal of achieving cash-flow positivity by the end of 2025, with Titan Partners Group serving as a key strategic advisor in financing initiatives and market expansion.

Quantum Computing Inc. (NASDAQ: QUBT), an integrated photonics and quantum optics technology company, announced it has entered into securities purchase agreements with institutional investors for the sale of 37,183,937 shares of common stock in an oversubscribed private placement priced at the market under Nasdaq rules. The offering, for expected gross proceeds of $750 million, is scheduled to close on or about Oct. 8, 2025, subject to customary conditions. Titan Partners Group, a division of American Capital Partners, acted as sole placement agent for the transaction. QCi plans to use the proceeds to accelerate commercialization, pursue strategic acquisitions, establish volume production capabilities, expand sales and engineering teams, and for working capital and general corporate purposes. CEO and Chairman Dr. Yuping Huang said the financing increases total capital raised since November 2024 to $1.64 billion, positioning QCi with one of the strongest balance sheets in the quantum sector and supporting its transition from a technology innovator to a leading quantum hardware manufacturer.

Numa Numa Resources is a mining and infrastructure development company focused on unlocking transformational opportunities in the Autonomous Region of Bougainville, where the company is headquartered and where its management has lived and worked for 10 years.

Cutaneous T-cell lymphoma (“CTCL”) is a rare but serious form of non-Hodgkin lymphoma that primarily affects the skin. Globally, millions suffer from CTCL, and in Europe, the annual incidence is estimated at 2.9 to 3.9 cases per million people ( https://ibn.fm/ANk8X ). Despite its rarity, CTCL presents a substantial unmet medical need, particularly in early-stage patients who often have limited treatment options. Addressing this gap, Soligenix (NASDAQ: SNGX) recently announced the expansion of its European Medical Advisory Board (“MAB”) ( https://ibn.fm/6354Y ) to provide additional clinical and strategic guidance as the company advances its confirmatory phase 3 study (referred to as FLASH2) evaluating the safety and efficacy of its proprietary CTCL treatment: HyBryte(TM).

Fifty 1 Labs (OTC: FITY), a cutting-edge innovator at the intersection of artificial intelligence, clinical research, and personalized wellness, announced the appointment of Dr. Joel Gagnier, BA, ND, MSc, PhD, as Chief Science Officer. A recognized leader in clinical epidemiology and research methodology, Dr. Gagnier currently serves as Associate Professor in Epidemiology & Biostatistics and Surgery at Western University’s Schulich School of Medicine & Dentistry. His expertise in clinical trial design, bias reduction, and patient-reported outcome measures (PROMs) strengthens Fifty1 AI Labs’ commitment to rigorous, evidence-based research, positioning the company to advance AI-driven solutions in musculoskeletal health, pain management, and personalized wellness.

In a groundbreaking move for sustainable boating, Vision Marine Technologies (NASDAQ: VMAR) has announced a strategic partnership with Port de plaisance La Ronde in Montreal, Quebec ( https://ibn.fm/ekBvm ). This collaboration aims to introduce the region’s first multilevel electric boating showcase, setting the stage for a new era in ecofriendly maritime experiences. A trailblazer in high-voltage marine propulsion systems, Vision Marine Technologies is renowned for its commitment to innovation and sustainability in the boating industry.

Louisiana is emerging as a center for strategic rare earth element production, and Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF) is poised to take full advantage. The company is advancing its Louisiana Strategic Metals Complex (“SMC”) at England Airpark in Alexandria, a commercial rare earth refining facility designed to strengthen the U.S. domestic supply chain for critical minerals essential to electric vehicles, renewable energy, and advanced defense technologies. Ucore’s efforts highlight why Louisiana is becoming an increasingly attractive location for rare earth operations.

CryptoCurrencyWire, an IBN (InvestorBrandNetwork) dynamic brand, publishes blockchain, decentralized finance, and crypto market news to audiences engaged in crypto hubs and industry media. With the addition of IgnitionX , that content is no longer just syndicated — it’s programmatically placed into the feeds of likely crypto investors. IgnitionX enables precision ad targeting across Google, Meta, YouTube, LinkedIn, TikTok, Reddit and more, using proprietary data to identify crypto-interested segments.

SuperCom (NASDAQ: SPCB), a global provider of secured solutions for the e-Government, Internet of Things (“IoT”) and cybersecurity sectors, has secured a new contract to provide alcohol monitoring technologies and services in California. The contract, which is for an initial three-year term and is valued at up to $3 million, was secured through SPCB’s wholly owned subsidiary Leaders in Community Alternatives (“LCA”). Noting that the contract further solidifies the company’s strong position in the electronic monitoring industry, SuperCom called the contract win another milestone for the company’s expansion into the U.S. market. According to the announcement, the contract is already in effect, running through 2026 with potential for extensions and recurring revenue.

ESGold (CSE: ESAU) (OTCQB: ESAUF), a gold exploration and development company, announced its inclusion in a NetworkNewsWire (“NNW”) editorial titled “As Investors Look for Safety, Gold Producers with Cash Flow Are Emerging as the Market’s Next Leaders.” The feature discusses how record gold prices, a weakening U.S. dollar, and sustained central bank buying are driving investor demand for well-managed mining equities. ESGold is positioned to capitalize on these trends with full funding, permits secured, and near-term production targeted for 2026, offering both scale and upside potential in a tightening gold market.

The start of this week saw the price of gold surge to new highs when it hit $3,958 an ounce. This makes its gain since the year began higher than 50%, its steepest annual climb since the oil shocks experienced in the 70s.

Germany will continue exempting electric vehicles from motor-vehicle taxes until 2035, a move the government says is essential to sustain momentum in its shift toward cleaner transport. Federal Finance Minister Lars Klingbeil confirmed the draft legislation this week, ending months of uncertainty surrounding the program after repeated warnings that tight public finances could curtail it .

For long, treatment approaches to glioblastoma, the deadliest form of brain cancer, have assumed that the disease is localized. However, a recent study has found that GBM erodes the skulls of its victims and this could partially explain why the current therapies have had dismal success rates against the tumors.

For decades, the United States has been the undisputed leader in global technology. Now China is determined to close the gap, investing heavily in AI, robotics, and the production of high-end semiconductor chips that power these industries. The government’s push aims to reduce its reliance on foreign suppliers and strengthen its position in the global tech race.

GlobalTech (OTC: GLTK), an AI and big data-focused tech holding company, launched an AI and Big Data Center of Excellence (“CoE”) – a multi-disciplinary ecosystem built to accelerate the adoption of AI and data driven transformation across global enterprises. The facility has the mission of enabling enterprises to navigate the evolving landscape through AI and Big Data innovative solutions and thought leadership.

Micropolis (NYSE American: MCRP), a pioneer in unmanned ground vehicles and AI-based security solutions, announced its participation in GITEX GLOBAL 2025, the world’s largest and most established technology exhibition, taking place Oct. 13–17 at the Dubai World Trade Centre. The Company will exhibit at Stand H4-A5 in Hall 4, where Founder and CEO Fareed Aljawhari and CFO Dzmitry Kastahorau will showcase advanced autonomous systems including the Robotic Forestry Unit, M0-2 Border Unit, M0-2 Platform, and Dubai Police M0-1 and M0-2 Patrol vehicles, highlighting Micropolis’s expanding capabilities across security, law enforcement, and industrial automation.

Safe & Green Holdings (NASDAQ: SGBX), a developer and designer of modular structures, announced it has regained compliance with all Nasdaq listing requirements, including Listing Rule 5550(a)(2) regarding the minimum $1.00 bid price. Nasdaq confirmed the matter closed as of Oct. 3, 2025. As part of its compliance plan, the Company restructured its agreement with Boral, cutting potential dilution by 80%, eliminating the Ace warrants, and resolving Nasdaq’s prior public interest concern related to potential share issuance. A subsequent reverse stock split reduced dilution by an additional 64%. CEO Mike McLaren said the milestone demonstrates Safe & Green’s commitment to strengthening its capital structure and advancing future growth.

Annovis Bio (NYSE: ANVS), a late-stage clinical drug platform company developing therapies for neurodegenerative diseases including Alzheimer’s and Parkinson’s, announced new results showing that buntanetap reduced key inflammatory biomarkers and improved neuronal integrity in Alzheimer’s patients. Data from the Phase 2/3 study demonstrated lower levels of IL-5, IL-6, S100A12, IFN-γ, and IGF1R in treated patients versus placebo, along with reduced neurofilament light chain (NFL), suggesting improved cellular health and potential disease-modifying effects. CEO Maria Maccechini said the findings confirm buntanetap’s multi-targeted mechanism and validate earlier preclinical and clinical results, advancing confidence in its potential to deliver meaningful therapeutic benefit.

Golf is experiencing a dynamic transformation, with young adults aged 18 to 34 emerging as the sport’s largest demographic. Newton Golf Company (NASDAQ: NWTG) is strategically positioned to meet the evolving needs of this vibrant group, offering innovative and high-quality golf equipment tailored to enhance their playing experience.

Eloro Resources (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM) a mineral exploration company, reported additional assay results from step-out holes DSB-88 and DSB-89 in the Silver-Zinc-Polymetallic Domain of its Santa Barbara starter pit area at the Iska Iska Project, confirming continued mineralization open to the east. The results include 1.72% Zn over 456m in hole DSB-88 and 1.27% Zn, 24.51 g/t Ag, and 0.54% Pb over 154.50m in hole DSB-89, among the strongest intersections to date. CEO Tom Larsen said the drilling is expanding and upgrading resources ahead of the Preliminary Economic Assessment, while Executive VP Dr. Osvaldo Arce noted that the Iska Iska property hosts two near-surface deposits potentially mineable from one large starter pit with a low stripping ratio.

Nutriband (NASDAQ: NTRB), a developer of prescription transdermal pharmaceutical products, announced the filing of a provisional patent application with the U.S. Patent and Trademark Office to expand protection for its AVERSA(TM) abuse-deterrent transdermal technology. The filing covers improved aversive formulations and coating application methods designed to enhance abuse deterrence and increase resistance to tampering. If converted to a non-provisional patent and granted, the new patent could extend AVERSA’s protection by up to 20 years from the filing date. AVERSA(TM) technology, already patented in 46 countries, incorporates aversive agents into transdermal patches to prevent misuse of drugs with abuse potential while maintaining accessibility for patients who require them..

Wall Street giant Morgan Stanley has encouraged investors to consider allocating between 2% and 4% of their portfolios to cryptocurrencies. The bank’s latest recommendation marks a notable shift in Wall Street’s tone toward digital assets, with Bitcoin taking the spotlight as a limited-supply asset often compared to gold in digital form.

The world of finance is changing fast, and one of the biggest shifts coming is tokenization. Both Wall Street and the crypto industry believe that turning real-world assets like stocks, bonds, and funds into digital tokens will completely reshape how global markets work. Tokenization means that traditional assets are recorded and traded on a blockchain, allowing investors to buy, sell, and settle transactions almost instantly.

Datavault AI (NASDAQ: DVLT), a leader in AI-driven data visualization, valuation, and monetization, announced a strategic partnership with leading Southwest U.S. radio station 99.7 FM to commercialize its patented ADIO(R) Inaudible Tones(R) technology. The one-year pilot integrates Datavault’s ADIO and Data Vault(R) data monetization services into 99.7 FM’s live events and advertising platforms, marking the first mainstream broadcast application of ADIO’s data-over-sound innovation. Co-Founder and CMO Sonia Choi, who initiated the collaboration, said 99.7 FM’s adoption “sets the stage for new revenue creation and expanded advertising inventory.” The pilot, pending FCC approval, will enable interactive, two-way audience engagement through sound-triggered mobile communications—bridging digital and physical experiences and advancing Datavault AI’s expansion across the $28.75 billion U.S. radio advertising market.

High employee turnover can hurt any company, but it’s especially tough in the marijuana business, where skilled workers are needed everywhere—from the dispensary counter to the cultivation room. As competition grows and margins tighten, keeping reliable, knowledgeable staff is not just an advantage; it’s what keeps a business running.

Platinum Group Metals (NYSE American: PLG) (TSX: PTM) is focused on the development of the world-class platinum group metal Waterberg deposit in South Africa. “Platinum and palladium are quietly becoming important to modern defense technology. From hydrogen fuel cells in armored vehicles to high-performance electronics in advanced aircraft, militaries worldwide are turning to these critical metals to power the next generation of strategic systems. Platinum Group Metals is well positioned to benefit from this trend, advancing the high-quality Waterberg Project that promises a reliable supply of platinum, palladium and associated metals for both defense and industrial applications,” reads a recent article. “In a market where technological advancement and geopolitical considerations intersect, Platinum Group Metals is positioning itself as an important supplier of metals that power innovation.”

HeartBeam (NASDAQ: BEAT) is on the verge of revolutionizing cardiac diagnostics with its groundbreaking ECG technology. A recent article discussing this reads, “HeartBeam plans to initiate commercialization immediately upon receiving FDA clearance. The company’s vision is to empower patients and healthcare providers by offering a portable, cable-free ECG solution that combines clinical-grade accuracy with ease of use. This innovation is poised to reduce the burden on healthcare facilities, improve patient engagement, and increase the availability of high-quality cardiac monitoring, particularly in underserved areas or for patients requiring frequent arrhythmia assessments.”

Fairchild Gold (TSX-V: FAIR) has signed a Memorandum of Understanding to acquire a 100% interest in the Golden Arrow Project, an advanced-stage gold property located along Nevada’s Walker Lane Shear Zone. As reported in an article by Ryan D. Long, the US$5 million transaction—valued at roughly US$12 per ounce of gold in the ground—will expand Fairchild’s total land position by 170% to 64.5 km² through the addition of Golden Arrow and the Nevada Titan Project.

NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, has re-filed an Abbreviated New Drug Application (“ANDA”) for KETAFREE(TM) , a preservative-free intravenous (“IV”) ketamine formulation intended for all currently approved ketamine indications. This follows FDA approval of NRx’s Suitability Petition… KETAFREE(TM) is designed to eliminate benzethonium chloride (“BZT”), a known neurotoxic and cytotoxic preservative still present in many ketamine formulations. NRx previously submitted a Citizen Petition urging the FDA to ban BZT from all IV ketamine products, citing long-term health risks and filing supporting toxicology evidence… In parallel, NRx is advancing NRX-100, a separate preservative-free ketamine formulation, under a New Drug Application (“NDA”) for treatment of suicidal depression, including bipolar depression. NRX-100 has received Fast Track Designation, and the company aims to qualify for the FDA’s National Priority Voucher Program. The two products—KETAFREE(TM) and NRX-100—will follow distinct regulatory and commercial paths. NRx is also developing NRX-101, an oral medication for suicidal bipolar depression, which holds Breakthrough Therapy Designation. With rising demand for ketamine and ongoing drug shortages, NRx aims to capture a significant market share while setting a new standard in preservative-free IV formulations.

Audius, the largest decentralized music discovery and marketplace platform, announced that verified artists can now create their own Solana-based crypto coins directly on the platform—marking a major step toward transforming traditional fan clubs into dynamic, tokenized communities. In just minutes, artists can mint branded coins to reward fans with access to exclusive music, private Discord channels, app-wide badges, and direct messages. The new Artist Coins provide a fresh revenue stream and deepen fan relationships, offering a new model for artist-driven engagement in the digital era.

NextPlat (NASDAQ: NXPL, NXPLW), a global consumer products and services company providing healthcare and technology solutions through e-commerce and retail channels, issued a shareholder update detailing operational progress and strategic initiatives for the remainder of 2025. Interim CEO Charles M. Fernandez reported that the company has implemented a comprehensive restructuring plan focused on cost reduction, operational efficiency, and growth acceleration. Recent actions include realignment of NextPlat’s healthcare management team under Progressive Care’s new Vice President of Healthcare Operations, Birute Norkute, and the identification of approximately $2 million in annualized expense savings. The company also reported significant progress across its three main divisions—healthcare, communications, and e-commerce—highlighting expanded government prescription contracts, upgrades to its AI-powered ClearMetrX 4.0 analytics platform, record recurring airtime revenue in satellite communications, and the global rollout of its Florida Sunshine supplement brand. NextPlat expects these combined initiatives to strengthen cash flow and position the company for sustainable growth through 2026.

OptimumBank Holdings (NYSE American: OPHC), a bank holding company that owns 100% of community bank OptimumBank, headquartered in Fort Lauderdale, Florida, is stepping onto the national stage in October with scheduled appearances at two high-profile conferences. The engagements highlight OptimumBank’s strategy of building visibility among investors, business leaders, and community stakeholders, while reinforcing its recent financial progress ( https://ibn.fm/rRYiQ ).

ESGold (CSE: ESAU) (OTCQB: ESAUF) announced that its geological and engineering team has arrived in Colombia to begin on-the-ground validation and due diligence at the Planta Magdalena Project, following the memorandum of understanding signed Aug. 20, 2025. The field program aims to confirm historic tailings grades, assess site infrastructure and throughput potential, and evaluate exploration opportunities across the Bolívar concession area. Bulk samples from both Colombia and Quebec have been shipped to ALS Global in Val-d’Or for metallurgical testing to verify gold and silver recoveries under ESGold’s clean-processing framework. “With our technical team now on the ground in Colombia, we’re moving from intent to execution,” said Gordon Robb, CEO. “This marks an exciting step forward in ESGold’s strategy to build a scalable, multi-jurisdictional platform for responsible gold and silver production.”

Izotropic (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3), a leading medical device firm in the field of breast cancer imaging solutions, is speeding up its efforts towards commercializing its innovations. Izotropic recently made public significant progress in its IzoView Breast CT system, a feature designed to give patients a customized radiation dose ideal for their composition and breast sizes ( ibn.fm/N83Cp ).

TransCode Therapeutics (NASDAQ: RNAZ) announced it has entered into a definitive agreement to acquire Polynoma LLC, a privately held immuno-oncology company developing seviprotimut-L, a late-stage polyvalent shed antigen vaccine for the adjuvant treatment of stage IIB and IIC melanoma. Concurrent with the acquisition, TransCode secured a $25 million investment from CK Life Sciences Int’l (Holdings) Inc. to fund its lead microRNA candidate, TTX-MC138, through a Phase 2 clinical trial. Philippe Calais, PharmD, PhD, was appointed Chief Executive Officer, succeeding Interim CEO Tom Fitzgerald, who returns to his role as CFO. “This acquisition allows us to create a unique and broader oncology pipeline with Phase 3-ready seviprotimut-L and our TTX-MC138 program,” said Dr. Calais. “Together, these assets position TransCode to deliver meaningful therapeutic advances for patients battling melanoma and metastatic disease.”

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM), a biopharmaceutical company advancing innovative treatments for neurodegenerative, metabolic, and alcohol misuse disorders, announced the implementation of a public whistleblower policy offering cash rewards of up to USD $7 million for verifiable evidence of stock manipulation involving the Company’s shares. Eligible participants may submit information directly to reward@quantumbiopharma.com or by calling 1-833-571-1811. The reward, payable from the net proceeds of the Company’s ongoing lawsuit, will be granted if the submitted information materially contributes to a final, non-appealable judgment or binding settlement in Quantum BioPharma’s favor. The initiative—approved by the board and audit committee with input from multiple law firms—underscores Quantum’s commitment to transparency, accountability, and market integrity while encouraging simultaneous reporting to the U.S. SEC and Canadian regulatory authorities.

Railtown AI Technologies (CSE: RAIL) (OTCQB: RLAIF), a leader in Canadian-built artificial intelligence solutions, announced that it has entered into an amalgamation agreement to acquire all issued and outstanding shares of AI Partnerships Corp. (AIP) through a three-cornered amalgamation, making AIP a wholly owned subsidiary of Railtown. The transaction involves the issuance of 40 million shares at a deemed price of $0.50 per share, plus 10 million performance shares tied to recurring revenue milestones. The acquisition supports Railtown’s goal of developing a first-of-its-kind AI affiliate marketplace designed to connect Canada’s AI ecosystem to secure, sovereign computing infrastructure. Following the transaction, Railtown will also benefit from AIP’s memorandum of understanding with DIGITAL, a national organization that links technology builders and buyers to accelerate commercialization. “Partnering with DIGITAL will empower Railtown and AIP affiliates to tap into a world-class network of innovators and ecosystem leaders,” said Tom Corr, CEO of AIP.

Oncotelic Therapeutics (OTCQB: OTLC) is a clinical-stage biopharmaceutical company advancing a diversified pipeline spanning oncology, immunotherapy, neurodegeneration, and rare diseases. In a recent interview on the BioMedWire podcast, Chairman and CEO Dr. Vuong Trieu emphasized the company’s unique model: focusing on de-risked, late-stage assets and accelerating their development through regulatory pathways designed for speed and efficiency.

Izotropic (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3), a medical device company developing imaging-based technologies for more accurate breast cancer screening, diagnosis, and treatment, marked Breast Cancer Awareness Month by emphasizing the limitations of current imaging tools and the significant opportunity for its flagship IzoView Breast CT Imaging System. With more than 2.3 million new breast cancer cases reported globally each year—and over 315,000 expected in the U.S. in 2025—Izotropic underscored the urgent need for true high-resolution 3D imaging, especially for women with dense breast tissue, which affects roughly 50% of women and diminishes the accuracy of compression-based screening. As the global breast imaging market grows from $5.4 billion in 2024 to a projected $8.69 billion by 2030, IzoView aims to address the unmet demand for superior diagnostic precision, reducing missed cancers, false positives, and costly follow-up procedures that currently total an estimated $8 billion annually in the U.S.

Oncotelic Therapeutics (OTCQB: OTLC), through its joint venture GMP Biotechnology Ltd. with Dragon Overseas Capital Ltd., announced that Sapu Nano presented its poster, “Sapu-003: Novel Intravenous Deciparticle(TM) Everolimus Entering Phase 1 Study in Australia,” at the 8th Australian Translational Breast Cancer Research Symposium (ATBCR 2025). The study marks the first clinical trial of an intravenous Deciparticle(TM) formulation of everolimus, an mTOR inhibitor used in breast cancer and other malignancies. Conducted in collaboration with SOCRU, Ingenū, and Medicilon, the trial (ACTRN12625001083482) is now enrolling patients with advanced HR+/HER2– breast cancer or other mTOR-sensitive tumors at leading oncology centers across Australia. “Sapu-003 represents a significant advance in the delivery of mTOR-targeted therapies,” said Dr. Vuong Trieu, CEO of Sapu Nano and Oncotelic. “Through these partnerships, we aim to accelerate development and bring this next-generation treatment to patients with advanced cancers.”

A new study from Ohio State University Wexner Medical Center has discovered why immunotherapy fails in 60-80% of cancer patients. Researchers identified a previously unknown stress pathway called TexPSR that floods weakened immune cells with misfolded proteins, crippling their ability to attack tumors. Blocking this pathway in laboratory models restored immune cell function and significantly improved immunotherapy effectiveness across multiple cancer types.

NetworkNewsWire Editorial Coverage : The economic narrative today goes beyond the simple fact that gold prices are climbing. It is also about a weakening U.S. dollar, easing real rates and a global push toward scarce, nonsovereign assets. Spot gold continues to reach new peaks, most recently trading more than $3,800 per ounce, as markets anticipate further Federal Reserve cuts alongside dollar softness. Silver has also surged, marking its highest point in some 14 years. Central banks remain steady buyers, having accumulated record volumes of gold since 2022, reinforcing the wider dedollarization trend. Against this backdrop, mining equities present an increasingly attractive opportunity. With gold setting all-time highs, the gap between bullion and well-managed mining firms is poised to narrow, offering investors significant leverage to the cycle. ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) ( Profile ) is one company well positioned to benefit, with a fully funded plan, permitting in place and near-term revenue potential. With production targeted for 2026, ESGold delivers both scale and upside that few juniors can match. The company stands out among a competitive field of mining players — including Teck Resources Limited (NYSE: TECK), B2Gold Corp. (NYSE AMERICAN: BTG), Hudbay Minerals Inc. (TSX: HBM) and Triple Flag Precious Metals Corp. (NYSE: TFPM) vying for attention in a precious metals market that is…

Nutriband (NASDAQ: NTRB) announced that Chairman Serguei Melnik will present at Noble Capital Markets’ Emerging Growth Virtual Equity Conference on Wednesday, Oct. 8, 2025, at 3 p.m. ET. The presentation will include a fireside Q&A session with questions from the live virtual audience, and registered investors can also schedule one-on-one meetings with Melnik. Interested attendees can register at no cost via the conference’s official site. A video webcast of the presentation will be available on Channelchek, Noble’s investor portal, and archived for 90 days on both Channelchek.com and Nutriband’s website.

For golfers aiming to elevate their performance, the equipment they choose can make all the difference. Newton Golf Company (NASDAQ: NWTG) is at the forefront of this philosophy, offering precision-engineered clubs and accessories designed to help players achieve consistency, power and control. The company’s dedication to innovation and quality has established it as a key player in the competitive golf equipment market, catering to both amateur enthusiasts and professional golfers alike.

A Yahoo! Finance article by Jake Conley reported that Trilogy Metals (NYSE American: TMQ) (TSX: TMQ) surged more than 200% after news that the Trump administration purchased a 10% equity stake valued at $35.6 million, with warrants for an additional 7.5% interest. The article detailed that President Trump also signed an executive order instructing federal agencies to reinstate and approve all required permits for the Ambler Access Project, a 211-mile industrial road that would connect Alaska’s mineral-rich Ambler Mining District to the state highway system. The district hosts substantial deposits of copper, cobalt, silver, gold, lead, and other critical metals essential to U.S. supply chains. The decision reverses a 2024 “No Action” ruling under the Biden administration and signals a renewed federal focus on developing domestic sources of strategic minerals.

Datavault AI (NASDAQ: DVLT) is redefining how technology and capital converge, turning its Q4 update into a blueprint for a new digital exchange economy. The company has established four Delaware corporations—the International Elements Exchange, International NIL Exchange, Information Data Exchange, and American Political Exchange—each designed to trade tokenized and stable assets beyond the reach of traditional markets. With regulatory clarity from Washington’s Clarity and Genius Acts paving the way, Datavault expects two of these exchanges to go live before year-end 2025, reflecting what management calls “growth by intention.” By aligning artificial intelligence, blockchain, and quantum computing into one scalable system, Datavault continues to execute ahead of the curve, transforming information into currency and infrastructure into opportunity.

GlobalTech (OTC: GLTK), a U.S.-based technology holding company specializing in artificial intelligence, big data, and digital infrastructure, is featured in the latest episode of The TechMediaWire Podcast produced by IBN, a multifaceted communications organization connecting public companies with the investment community. In the episode, GlobalTech President Frank R. Parrish III discusses the company’s mission to create value through collaboration and technology-driven innovation, outlining its dual-vertical strategy that combines proprietary AI and big data product development with value-added acquisitions. Parrish also highlights GlobalTech’s rapid global expansion, with active operations across the United States, the United Kingdom, the European Union, the Middle East, and Australia.

On Monday, President Trump issued an order approving the construction of a road running 211 miles so that the mining of copper, zinc and other critical minerals could commence at a site in Alaska. The project had been halted during the presidency of Biden in order to cut emissions, protect tribal lands and preserve flora and fauna habitats.

Trilogy Metals (NYSE American: TMQ) (TSX: TMQ), a base metals exploration and development company advancing its Arctic and Bornite projects in Alaska’s Ambler Mining District, has been added to the BillionDollarClub (BDC), an InvestorBrandNetwork (IBN) platform that spotlights innovative small- and mid-cap companies with billion-dollar potential. The recognition underscores Trilogy’s strong positioning in critical minerals including copper, zinc, lead, gold, and silver—key resources driving the global energy transition.

California is showing the world how solar power and battery storage can completely change the way we produce and use energy. In 2025, the state reached a historic milestone when its solar farms produced more electricity than fossil fuel plants for the first time over a long period. This marks a major step in America’s transition to cleaner and more sustainable energy.

Nebraska marijuana officials have missed the deadline to issue medical cannabis growing licenses, creating fresh frustration for supporters of the voter-approved law. The setback is the latest sign of political resistance in several GOP-led states against marijuana legalization.

D-Wave Quantum Inc. (NYSE: QBTS) and North Wales Police (NWP) completed a joint proof-of-technology project using a hybrid-quantum application to optimize police vehicle placement, cutting response times by nearly 50% and reducing coordination planning from four months to four minutes. The test also demonstrated that NWP could respond to at least 90% of incidents within their target response time using the hybrid-quantum application. Following the successful project, the UK Office of the Chief Scientific Adviser for Policing recognized it to be of national cross-government departmental interest with opportunity for future development and deployment. The project highlights the importance and value of cross-border collaboration, with D-Wave TM technology—developed in Canada by a U.S. company—addressing a key UK public sector challenge.

Nightfood Holdings (OTCQB: NGTF), doing business as TechForce Robotics, announced the closing of its fifth acquisition in less than two years with the purchase of Treasure Mountain Holdings, LLC, owner of the 120-room Hilton Garden Inn Rancho Mirage in California, for approximately $52.8 million. The transaction advances the company’s transformation into a technology-driven enterprise, integrating real estate assets with its Robotics-as-a-Service (RaaS) platform to create AI-connected environments for testing and deploying service robots. CEO Jimmy Chan said the acquisition “marks another defining step” toward building a vertically integrated robotics ecosystem that merges automation innovation with asset-backed stability and recurring revenue potential.

Beeline Holdings (NASDAQ: BLNE), a fast-growing digital mortgage platform redefining the path to homeownership, is featured in the latest episode of The TechMediaWire Podcast from IBN, a multifaceted communications organization connecting public companies with the investment community. In the interview, CEO and Co-Founder Nick Liuzza outlines Beeline’s mission to modernize mortgage lending for millennial and Gen Z buyers, highlights the leadership team’s personal financial investment in the company, and details its accelerated trajectory toward profitability—achieving debt-free status ahead of schedule and targeting positive cash flow by Q1 2026. To listen to the full episode, visit The TechMediaWire Podcast .

Massimo Group (NASDAQ: MAMO), a leading manufacturer and distributor of powersports vehicles, announced the nationwide availability of its all-new Sentinel 570 HVAC UTV, the debut model in its premium Sentinel Series. Designed for year-round comfort and performance, the 500-class utility vehicle features a fully enclosed, climate-controlled cabin, touchscreen GPS display, on-demand 4WD, and independent suspension. CEO David Shan said the Sentinel 570 “delivers a complete package of power, comfort, and advanced technology,” reinforcing the company’s commitment to innovation across work and recreational applications. Additional Sentinel models, including the 770, 900, and 1500, are slated for 2026 release.

Forward Industries (NASDAQ: FORD), a leading Solana treasury company, announced the launch of its institutional-grade validator node on the Solana blockchain, powered by DoubleZero’s high-performance global network for distributed systems. Developed in collaboration with Galaxy and leveraging Jump Crypto’s Firedancer client, the validator operates at 0% commission, allowing users to stake at no cost while supporting Forward’s transition from capital provider to active ecosystem contributor. Chairman Kyle Samani said the initiative aligns Forward with blockchain infrastructure leaders and strengthens Solana’s scalability and institutional readiness, marking a key milestone in the company’s evolution within decentralized finance.

ESGold (CSE: ESAU) (OTCQB: ESAUF) announced its inclusion in a NetworkNewsWire editorial titled “When the Dollar Blinks, Real Assets Take Center Stage,” which explores how a weakening U.S. dollar and record-high gold prices are driving renewed investor interest in real assets. With gold recently trading near $3,700 per ounce and silver reaching 14-year highs, the article highlights ESGold’s strong positioning in this environment, citing its fully funded, permit-backed business plan and pathway to production in 2026 as offering near-term profit potential and significant leverage to the ongoing gold cycle.

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company developing treatments for rare diseases, announced that its Data Monitoring Committee has completed its first review of the confirmatory Phase 3 FLASH2 study of HyBryte(TM) (synthetic hypericin) in cutaneous T-cell lymphoma, concluding there are no safety concerns and that the therapy maintains an acceptable safety profile consistent with prior trials. Enrollment is progressing on schedule, with an update expected in Q4 2025 and a blinded interim efficacy analysis planned for 1H 2026. The FLASH2 trial builds on the Company’s earlier statistically significant Phase 3 results and additional supportive studies demonstrating HyBryte’s efficacy and tolerability as a potential first-line treatment option for early-stage CTCL.

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) is transforming the biotechnology landscape through a digitally integrated model that merges clinical innovation, consumer health commercialization, and market infrastructure modernization. Anchored by its flagship neuroprotective program, Lucid-MS, developed with Massachusetts General Hospital to address demyelination in multiple sclerosis, the company is expanding beyond traditional R&D into scalable, data-driven operations. Quantum’s portfolio includes Celly Nu’s unbuzzd(TM) beverage and a dual listing on Upstream, positioning it as a next-generation public issuer that unites science, transparency, and capital efficiency. By aligning biotech development with advanced trading and investor-access technologies, Quantum BioPharma is emerging as a prototype for the digitally engineered life sciences enterprise.

Oragenics (NYSE American: OGEN), a clinical-stage biotechnology company advancing brain-targeted therapies through proprietary intranasal delivery technology, announced a strategic collaboration with Receptor.AI to accelerate the development of new drug candidates for neurological conditions. The partnership will apply AI-based receptor modeling to optimize binding profiles for compounds acquired in 2023, supporting Oragenics’ expansion beyond its lead candidate, ONP-002, in concussion. CEO Janet Huffman said the collaboration underscores the company’s evolution into a diversified neurological therapeutics developer, combining artificial intelligence and precision delivery to streamline preclinical discovery and enhance capital efficiency.

BioAdaptives (OTCMKTS: BDPT) announced the commercial launch of MyndMed(TM), a next-generation dietary supplement designed to enhance memory, focus, and overall brain performance. Following extensive testing with highly positive user feedback, the company is scaling production and expanding distribution to meet anticipated high demand beginning in November. Formulated to support cognitive function across short-, mid-, and long-term pathways, MyndMed(TM) delivers what the company calls “Mental Armor for Modern Minds(TM)” through clinically studied ingredients that promote alertness, neuroplasticity, and cellular energy balance. Manufactured in the U.S. in cGMP-certified facilities and third-party tested for purity, MyndMed(TM) is available nationwide at www.MyndMed.com.

Recently, Intellistake Technologies Corporation, a tech company that develops AI software solutions, revealed a partnership with PowerBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: 103), a premier developer and owner of renewable and clean energy projects ( https://ibn.fm/REgL8 ).

Fathom Nickel (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) announced it has completed the final cash payment and share issuance required under the Gochager Lake Earn-In Agreement, granting the Company full ownership of the Gochager Lake Property in Saskatchewan, subject to a 2% NSR royalty. Since entering the agreement in 2022, Fathom has expanded the property from 4,696 to over 34,000 hectares, advanced its geological model, and extended the mineralized corridor to more than 1.4 kilometers. CEO Ian Fraser said the milestone marks significant progress toward establishing a district-scale nickel camp through continued science-driven exploration.

PowerBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: 103), a North American energy infrastructure developer and asset owner, announced it has executed a lease agreement for its 6.9 MW DC NY-Crawford Rd ground-mount solar project in New York’s Capital District. Expected to qualify for incentives under NYSERDA’s NY-Sun Program, the project will deliver clean, cost-saving power to local residents through a community solar model. PowerBank is advancing interconnection and permitting steps while securing project financing, leveraging its track record of over 100 MW of completed solar projects and a 1 GW development pipeline to support New York’s 6 GW solar capacity goal under the state’s Climate Leadership and Community Protection Act.

Early and accurate detection of heart rhythm problems can mean the difference between life-saving intervention and a missed opportunity, which is why new advances in cardiac diagnostics carry such weight. HeartBeam (NASDAQ: BEAT) has reported promising results from its pivotal VALID-ECG study ( https://ibn.fm/BDiIa ), demonstrating that its synthesized 12-lead ECG technology delivers a strong correlation with the clinical gold standard of traditional 12-lead ECGs for non-life-threatening arrhythmias.

SEGG Media (NASDAQ: SEGG, LTRYW), the global sports, entertainment, and gaming conglomerate, announced a highly successful opening weekend for the Super League Kerala streamed live on its Sports.com platform. The event featured three competitive matches drawing more than 517,000 digital viewers with an average watch time of 60 minutes, alongside strong stadium attendance led by Calicut FC’s 2-1 victory over Forca Kochi FC. Backed by sponsors Sports.com and Amul, with Sony handling linear broadcasts, the SLK launch marked a milestone in Sports.com’s expansion across India and MENA, reinforcing its strategy to drive fan engagement, sponsorship revenue, and global football streaming growth.

This past week, BHP announced its plan to invest over $555.1 million dollars in its Olympic Dam project. The project is located in the province of South Australia, on the traditional lands of the Arabana, Dieri, and Kokatha people. This province has 3 underground mines in Carrapateena, Prominent Hill, and Olympic Dam.

British battery electric vehicle sales surged nearly one-third in September compared to the previous year, reaching 72,800 units. The record figures followed the UK government’s July reintroduction of electric car grants worth up to £3,750 ($5,035), responding to intense carmaker lobbying about struggles meeting mandatory zero-emission vehicle targets.

While immunotherapy has scored a significant level of success in treating many types of cancer, it hasn’t registered similar efficacy in leukemia, especially acute myeloid leukemia, also known as AML. Researchers at Lund University, Sweden have found a possible reason why this could be so.

At only 23 years old, Jacob Palmer has already built a successful career as an electrician and business owner. He started the company in 2024 after deciding college wasn’t the right path for him. Looking back, he has no regrets about skipping higher education. “I’m really happy doing this because it’s given me independence,” he said.

Gold exploration and development company LaFleur Minerals (CSE: LFLR) (OTCQB: LFLRF) expects to wrap up a comprehensive Preliminary Economic Assessment (“PEA”) for its drilling project in the Abitibi Greenstone Belt of Quebec, Canada by the end of October, moving its gold exploration forward even as the company prepares to restart production at its gold mill operation for near-term revenues.

NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, announced it has received approval from the U.S. Food and Drug Administration (“FDA”) for its Suitability Petition to advance KETAFREE(TM), a preservative-free version of ketamine ( https://ibn.fm/qFzsh ). The ruling allows the company to re-file its Abbreviated New Drug Application (“ANDA”) for the product, which it has now done, a key step in bringing it to market ( https://ibn.fm/nogJi ).

Renewable energy is fundamentally reshaping global economics, with clean energy sectors accounting for 10% of worldwide GDP growth in 2023. China’s renewable sector drove nearly one-fifth of the country’s 5.2% economic expansion while the European Union saw roughly a third of its growth fueled by clean energy.

Russia is taking steps to create its own system for managing crypto transactions through government-backed infrastructure.